Skip to main content
. 2016 Jul 7;7(33):53277–53288. doi: 10.18632/oncotarget.10467

Figure 3. The effect of perineoplasm PAT CMs from patients with benign renal diseases or different tumor stages of ccRCC on proliferation and migration of ACHN cells.

Figure 3

A. the proliferation of ACHN cells was assayed as described above. Perineoplasm PAT CMs from patients with benign renal diseases increase the proliferation of ACHN cells (P<0.05), whereas perineoplasm PAT CMs from patients with pT3 ccRCC decrease the proliferation of ACHN cells (P<0.05). B. the migration of ACHN cells were examined as described above. Perineoplasm PAT CMs from patients with pT3 ccRCC significantly increase the migration of ACHN cells compared to those from patients with benign renal diseases or pT1 or pT2 ccRCC (Ps<0.05). C. representative pictures of migrated ACHN cells were taken from the lower surface of three independent membranes at ×100 magnification. Arrows indicate invaded cells.